A Phase 1/2 Trial of Reirradiation for Diffuse Intrinsic Pontine Glioma

被引：0
|
作者：
Krishnatry, Rahul [1 ]
Manjali, Jifmi Jose [1 ]
机构：
[1] Tata Mem Hosp, Homi Bhabha Natl Inst, Dept Radiat Oncol, Mumbai, Maharashtra, India
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2019年 / 104卷 / 02期
关键词：
RADIATION;
D O I：
10.1016/j.ijrobp.2019.02.038
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：467 / 468
页数：4
相关论文
共 50 条
  • [41] Reirradiation and PD-1 inhibition with nivolumab for the treatment of recurrent diffuse intrinsic pontine glioma: a single-institution experience
    Kline, Cassie
    Liu, S. John
    Duriseti, Sai
    Banerjee, Anuradha
    Nicolaides, Theodore
    Raber, Shannon
    Gupta, Nalin
    Haas-Kogan, Daphne
    Braunstein, Steve
    Mueller, Sabine
    JOURNAL OF NEURO-ONCOLOGY, 2018, 140 (03) : 629 - 638
  • [42] Reirradiation and PD-1 inhibition with nivolumab for the treatment of recurrent diffuse intrinsic pontine glioma: a single-institution experience
    Cassie Kline
    S. John Liu
    Sai Duriseti
    Anuradha Banerjee
    Theodore Nicolaides
    Shannon Raber
    Nalin Gupta
    Daphne Haas-Kogan
    Steve Braunstein
    Sabine Mueller
    Journal of Neuro-Oncology, 2018, 140 : 629 - 638
  • [43] THE EFFECTS OF MTOR COMPLEX 1/2 INHIBITION ON DIFFUSE INTRINSIC PONTINE GLIOMA CELLS
    Flannery, Patrick
    DeSisto, John
    Amani, Vladimir
    Venkataraman, Sujatha
    Vibhakar, Rajeev
    Green, Adam
    NEURO-ONCOLOGY, 2016, 18 : 76 - 76
  • [44] Preclinical analysis of MTOR complex 1/2 inhibition in diffuse intrinsic pontine glioma
    Flannery, Patrick C.
    DeSisto, John A.
    Amani, Vladimir
    Venkataraman, Sujatha
    Lemma, Rakeb T.
    Prince, Eric W.
    Donson, Andrew
    Moroze, Erin E.
    Hoffman, Lindsey
    Levy, Jean M. Mulcahy
    Foreman, Nicholas
    Vibhakar, Rajeev
    Green, Adam L.
    ONCOLOGY REPORTS, 2018, 39 (02) : 455 - 464
  • [45] Reirradiation for Diffuse Intrinsic Pontine Gliomas in Children: Clinical and Radiomic Analysis
    Wawrzuta, D.
    Chojnacka, M.
    Pedziwiatr, K.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S765 - S766
  • [46] Phase I Trial of DNX-2401 for Diffuse Intrinsic Pontine Glioma Newly Diagnosed in Pediatric Patients
    Tejada, Sonia
    Alonso, Marta
    Patino, Ana
    Fueyo, Juan
    Gomez-Manzano, Candelaria
    Diez-Valle, Ricardo
    NEUROSURGERY, 2018, 83 (05) : 1050 - 1056
  • [47] Phase I Trial, Pharmacokinetics, and Pharmacodynamics of Vandetanib and Dasatinib in Children with Newly Diagnosed Diffuse Intrinsic Pontine Glioma
    Broniscer, Alberto
    Baker, Sharyn D.
    Wetmore, Cynthia
    Panandiker, Atmaram S. Pai
    Huang, Jie
    Davidoff, Andrew M.
    Onar-Thomas, Arzu
    Panetta, John C.
    Chin, Thomas K.
    Merchant, Thomas E.
    Baker, Justin N.
    Kaste, Sue C.
    Gajjar, Amar
    Stewart, Clinton F.
    CLINICAL CANCER RESEARCH, 2013, 19 (11) : 3050 - 3058
  • [48] A PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN PEDIATRIC RECURRENT DIFFUSE INTRINSIC PONTINE GLIOMA
    Burzynski, Stanislaw
    Janicki, Tomasz
    Burzynski, Gregory
    Marszalek, Ania
    NEURO-ONCOLOGY, 2013, 15 : 103 - 103
  • [49] Immune Microenvironment and Immunotherapies for Diffuse Intrinsic Pontine Glioma
    Chen, Yujia
    Zhao, Chao
    Li, Shenglun
    Wang, Jun
    Zhang, Hongwei
    CANCERS, 2023, 15 (03)
  • [50] Epigenetic Targeted Therapy for Diffuse Intrinsic Pontine Glioma
    Hashizume, Rintaro
    NEUROLOGIA MEDICO-CHIRURGICA, 2017, 57 (07) : 331 - 342
12345